Driving Habits May Help Identify Preclinical Alzheimer Disease
Investigators installed GPS data loggers with custom software in participants’ vehicles to see if driving performance could predict preclinical Alzheimer disease.
Neurocognitive Disorders
Obesity With Cardiometabolic Abnormalities Tied to Cognitive Decline
For Hispanics/Latinos, central obesity in the presence of cardiometabolic abnormality is associated with poorer cognitive trajectories.
Cognitive Decline May Up Bone Loss, Fracture Risk in Older Women
There is a significant association between cognitive decline and both bone loss and fracture risk, independent of aging, in community-dwelling, older women.
Tau Positron Emission Tomography Better Predicts Cognitive Decline Among Patients With Alzheimer Disease
The researchers sought to understand the prognostic value of tau positron emission tomography for predicting cognitive decline across the clinical spectrum of Alzheimer disease.
Relationship Between Kawasaki Disease Heterogeneity and Cognitive Development of Patients, Caregiver Stress
Study researchers sought to assess the link between Kawasaki disease and patient cognitive profiles or caregiver parenting stress.
Reading Problems in Childhood Tied to Poorer Memory Scores in Adulthood
Reading problems in childhood are associated with poorer memory scores at age 43 years, but not with rate of memory decline.
Understanding the Relationship Between Alzheimer Disease and HIV
Study researchers sought to differentiate between HIV-associated neurocognitive disorder and true Alzheimer disease in patients with HIV.
Can Autoantibodies Be Used as Biomarkers for the Diagnosis of Neuropsychiatric Systemic Lupus Erythematosus?
In this review, the author discusses the use of autoantibodies as biomarkers for the differential diagnosis of neuropsychiatric systemic lupus erythematosus.
Gluten Intake Not Tied to Cognition in Women Without Celiac Disease
Long-term gluten intake is not associated with cognitive scores in middle-aged women without celiac disease
Donanemab Therapy Modestly Reduces Cognitive and Functional Decline Among Patients With Early Alzheimer Disease
The accumulation of amyloid-β (Aβ) peptide is a sign of Alzheimer disease (AD). The researchers investigated donanemab, an antibody that targets a modified form of deposited Aβ, as a method for treating early AD.
- Loading...
Loading...
Next post in Alzheimer Disease and Dementia
Loading... 
Loading...